Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Peer Christiansen"'
Autor:
Stephen Hamilton-Dutoit, Maret L. Maliniak, Henrik Toft Sørensen, Kristina B. Christensen, Per Damkier, Peer Christiansen, Timothy L. Lash, Lindsay J Collin, Sinna Pilgaard Ulrichsen, Deirdre Cronin-Fenton, Rami Yacoub, Thomas P. Ahern
Publikováno v:
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast cancer research : BCR, vol. 23, no. 1, pp. 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research : BCR
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, no. 1, 103 . https://doi.org/10.1186/s13058-021-01480-1
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, no. 1, 103 . https://doi.org/10.1186/s13058-021-01480-1
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Background Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor that facilitates the adaptation of cancer cells to hypoxic conditions and may be prognostic of breast cancer recurrence. We evaluated the association of HIF-1α expression wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e39bc949916f4137cca5c5dfff01a5
https://pure.au.dk/portal/da/publications/hypoxiainducible-factor1-expression-and-breast-cancer-recurrence-in-a-danish-populationbased-case-control-study(68e72280-51af-4af2-8ec1-638d84a3abdc).html
https://pure.au.dk/portal/da/publications/hypoxiainducible-factor1-expression-and-breast-cancer-recurrence-in-a-danish-populationbased-case-control-study(68e72280-51af-4af2-8ec1-638d84a3abdc).html
Autor:
Trine Tramm, Stephen Hamilton-Dutoit, James W. Baurley, Kristina Lystlund Lauridsen, Per Damkier, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Kristina B. Christensen, Maret L. Maliniak, Rebecca A. Silliman, Deirdre Cronin-Fenton, Timothy L. Lash, Michael E. Zwick, Thomas P. Ahern, Bent Ejlertsen, R. Benjamin Isett, Rebecca Nash, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K, Silliman, R A, Toft Sørensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin-Fenton, D 2020, ' Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients ', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Background: Tamoxifen and its metabolites compete with estrogen to occupy the estrogen receptor. The conventional dose of adjuvant tamoxifen overwhelms estrogen in this competition, reducing breast cancer recurrence risk by nearly half. Phase I metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801d69fb5cd7b94c2ec62c58bf25321
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
Autor:
Sinna Pilgaard Ulrichsen, Henrik Toft Sørensen, Lauren E. McCullough, Michael Goodman, Kristina B. Christensen, Kristina Lystlund Lauridsen, Per Damkier, Rami Yacoub, Lance A. Waller, Timothy L. Lash, Thomas P. Ahern, Bent Ejlertsen, Deirdre Cronin-Fenton, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit
Publikováno v:
Collin, L J, Ulrichsen, S P, Ahern, T P, Goodman, M, McCullough, L E, Waller, L A, Bang Christensen, K, Damkier, P, Hamilton-Dutoit, S, Lauridsen, K L, Yacoub, R, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Cronin-Fenton, D P & Lash, T L 2020, ' 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence : a Danish population-based study ', Acta Oncologica, vol. 59, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2019.1684560
Acta Oncol
Acta Oncol
BACKGROUND: Approximately 20–40% of patients diagnosed with breast cancer will experience a recurrence up to 20 years after their original diagnosis. 17?-hydroxysteroid dehydrogenase 1 and 2 (HSD17B1 and HSD17B2, respectively) regulate intratumoral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1221ea8ab1bf3d1024c9bb6d4f0751
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
Autor:
Per Damkier, Thomas P. Ahern, Stephen Hamilton-Dutoit, Anders Kjærsgaard, Lindsay J Collin, Peer Christiansen, Kristina B. Christensen, Deirdre Cronin-Fenton, Kristina Lystlund Lauridsen, Timothy L. Lash, Henrik Toft Sørensen, Rami Yacoub
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Damkier, P, Hamilton-Dutoit, S, Kjaersgaard, A, Lauridsen, K L, Yacoub, R, Christiansen, P, Sørensen, H T & Lash, T L 2019, ' Expression of survivin does not appear to influence breast cancer recurrence risk ', Acta Oncologica, vol. 58, no. 2, pp. 154-161 . https://doi.org/10.1080/0284186X.2018.1503419
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells.METHODS: We estimated the association between nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c5d4567c22bdcc224bb419fa7029e9
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html